PALISADE BIO INC (PALI) Stock Analyst Ratings
USA - NASDAQ:PALI - US6963894026 - Common Stock
0.6001 USD
+0 (+0.35%)
0.6024 USD
+0 (+0.38%)
ChartMill assigns a Buy % Consensus number of 84% to PALI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 1259.77% above the current price.
PALI was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PALI.
In the previous month the buy percentage consensus was at a similar level.
PALI was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-13 | Brookline Capital | Maintains | Buy -> Buy |
| 2024-11-20 | Brookline Capital | Initiate | Buy |
| 2024-11-13 | Maxim Group | Maintains | Buy -> Buy |
| 2024-05-01 | Maxim Group | Reiterate | Buy -> Buy |
| 2024-04-16 | Maxim Group | Maintains | Buy -> Buy |
| 2023-11-17 | Maxim Group | Upgrade | Hold -> Buy |
| 2023-05-16 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2023-03-30 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-08-19 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-02-02 | Ladenburg Thalmann | Initiate | Buy |
| 2021-08-31 | Maxim Group | Initiate | Buy |